Evidence map›Paper›PMID 40307686›Full record

ArticleMolecular medicine (Cambridge, Mass.)2025

Surfactant protein D alleviates chondrocytes senescence by upregulating SIRT3/SOD2 pathway in osteoarthritis.

Huanyu Jiang, Yantao Zhang, Piyao Ji, Jianghua Ming, Yaming Li, Yan Zhou

Abstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huanyu Jiang *Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Yantao Zhang *Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Piyao Ji *Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Jianghua MingDepartment of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Yaming LiDepartment of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Yan ZhouDepartment of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, 430060, China. yanzhou0827@whu.edu.cn.

Funding

National Natural Science Foundation of China 82272528Natural Science Foundation of Hubei Province 2022CFB117
6 · The paper itself

Abstract

backgroundOsteoarthritis (OA) is an age-related degenerative disease that affects bones and joints. The hallmark pathogenesis of OA is associated with chondrocyte senescence. Surfactant protein D (SP-D) is a member of the innate immune proteins family, which can inhibit the immune inflammatory response of chondrocytes. However, the effect of SP-D on chondrocyte senescence phenotype is poorly studied. The present study investigated the phenotypic regulation of OA chondrocyte senescence mediated by SP-D and explored the underlying molecular mechanism.

methodsIn this study, an in vitro senescence chondrocyte model was generated by subjecting chondrocytes to IL-1β treatment. Furthermore, the expression of aging-related biomarkers and mitochondrial functions in SP-D overexpressing chondrocytes was observed. Co-immunoprecipitation was conducted to verify the association between SP-D and the identifed proteins within chondrocytes. Moreover, a rat OA model was established by destabilization of the medial meniscus surgery, and the effect of SP-D on reversing the aging phenotype of OA cartilage was investigated.

resultsThe results indicated that SP-D significantly decreased senescence and enhanced mitochondrial functions in senescent chondrocytes. The RNA-sequencing analysis revealed that the SIRT3/SOD2 pathway predominantly modulated the effect of SP-D on alleviating senescence. In addition, SP-D overexpression mitigated chondrocyte senescence, suppressed senescence-associated secretory phenotype (SASP) secretion and ameliorated mitochondrial damage. In the rat OA model, SP-D inhibited aging-related pathological changes by upregulating SIRT3/SOD2 pathway, thereby protecting the cartilage tissue integrity.

conclusionThese findings indicate that SP-D modulates the inhibition of chondrocyte senescence by upregulating SIRT3/SOD2 pathway. These data indicate that targeting SP-D and the SIRT3/SOD2 pathway might be a promising therapeutic strategy for OA.

Indexed as

Cellular SenescenceChondrocytesOsteoarthritisPulmonary Surfactant-Associated Protein DSirtuin 3AnimalsCells, CulturedDisease Models, AnimalHumansMaleMitochondriaRatsRats, Sprague-DawleySignal TransductionSuperoxide DismutaseSuperoxide Dismutase 2Pulmonary Surfactant-Associated Protein DSIRT3 protein, humanSirtuin 3Superoxide DismutaseSuperoxide Dismutase 2ChondrocyteMitochondriaOsteoarthritisSenescenceSirtuinSuperoxide dismutaseSurfactant protein D

Identifiers

PMID40307686
PMCPMC12044875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.